Peer-reviewedCC BY-NC-ND 4.0Npj Autoimmunity
High-dimensionality approaches to the understanding and therapeutic manipulation of autoimmunity
- 1Translational Immunology Institute, SingHealth/Duke-NUS Academic Medical Centre, Singapore, Singapore
- 2Duke-NUS Medical School, Singapore, Singapore
Abstract
Autoimmune disease may arise from disruptions in immune architecture rather than isolated molecular defects. High-dimensional immunology now reveals dynamic cellular states, regulatory circuits, and tissue-specific immune niches, but translation into therapy remains limited. We propose an Architecture-Anomaly-Target-Lead framework that contextualises therapeutic targets within immune organisation and complements Reset-Rebuild strategies. Together, these concepts provide a framework for developing and evaluating more sustained, tolerance-focused treatment approaches for autoimmune disease.
Related
- Understanding ROS signaling and evolution during animal regeneration offers promising opportunities for novel therapeutic approaches
- TIGIT+ B cells: emerging immunoregulatory players in autoimmunity and transplantation tolerance with therapeutic potential
- Emerging Roles of PSTPIP2 in Autoimmunity: From Mechanism to Therapeutic Implications
- Novel Therapeutic Targets and Approaches, Genetic Markers and Signaling Pathways in Neoplasms—An Overview
- Therapeutic approaches to cellular stress response
BibTeX
@article{chellamuthu2026highdimensionality,
title = {{High-dimensionality approaches to the understanding and therapeutic manipulation of autoimmunity}},
author = {Vasuki-Ranjani Chellamuthu and Yunqian Zhao and Salvatore Albani},
journal = {Npj Autoimmunity},
year = {2026},
month = oct,
doi = {10.1038/s44483-026-00007-0},
url = {https://doi.org/10.1038/s44483-026-00007-0},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - High-dimensionality approaches to the understanding and therapeutic manipulation of autoimmunity
AU - Vasuki-Ranjani Chellamuthu
AU - Yunqian Zhao
AU - Salvatore Albani
PY - 2026
DA - 2026/10/31
JO - Npj Autoimmunity
DO - 10.1038/s44483-026-00007-0
UR - https://doi.org/10.1038/s44483-026-00007-0
AB - Autoimmune disease may arise from disruptions in immune architecture rather than isolated molecular defects. High-dimensional immunology now reveals dynamic cellular states, regulatory circuits, and tissue-specific immune niches, but translation into therapy remains limited. We propose an Architecture-Anomaly-Target-Lead framework that contextualises therapeutic targets within immune organisation and complements Reset-Rebuild strategies. Together, these concepts provide a framework for developing and evaluating more sustained, tolerance-focused treatment approaches for autoimmune disease.
SN - 3091-2792
ER -